+

WO2009060621A1 - 術後の癒着を抑制するための医療用組成物 - Google Patents

術後の癒着を抑制するための医療用組成物 Download PDF

Info

Publication number
WO2009060621A1
WO2009060621A1 PCT/JP2008/003228 JP2008003228W WO2009060621A1 WO 2009060621 A1 WO2009060621 A1 WO 2009060621A1 JP 2008003228 W JP2008003228 W JP 2008003228W WO 2009060621 A1 WO2009060621 A1 WO 2009060621A1
Authority
WO
WIPO (PCT)
Prior art keywords
medical composition
surgical adhesion
preventing post
adhesion
post
Prior art date
Application number
PCT/JP2008/003228
Other languages
English (en)
French (fr)
Inventor
Shouji Ooya
Tetsuo Hiratou
Kentaro Nakamura
Original Assignee
Fujifilm Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corporation filed Critical Fujifilm Corporation
Publication of WO2009060621A1 publication Critical patent/WO2009060621A1/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)

Abstract

　本発明の目的は、薬剤貯蔵、徐放用担体としての機能を保持しつつ、特に心筋組織での繊維組織形成を抑制し、かつ、周辺組織との癒着を抑制することができる医療用組成物を提供することである。本発明によれば、架橋されたアルブミンを含有する、術後の癒着を抑制するための医療用組成物が提供される。  
PCT/JP2008/003228 2007-11-08 2008-11-07 術後の癒着を抑制するための医療用組成物 WO2009060621A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-290552 2007-11-08
JP2007290552 2007-11-08

Publications (1)

Publication Number Publication Date
WO2009060621A1 true WO2009060621A1 (ja) 2009-05-14

Family

ID=40625528

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/003228 WO2009060621A1 (ja) 2007-11-08 2008-11-07 術後の癒着を抑制するための医療用組成物

Country Status (1)

Country Link
WO (1) WO2009060621A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102362856A (zh) * 2011-11-02 2012-02-29 珠海亿胜生物制药有限公司 重组牛碱性成纤维细胞生长因子外用溶液

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002020310A (ja) * 2000-06-30 2002-01-23 Nipro Corp 組織癒着防止剤
WO2006016600A1 (ja) * 2004-08-10 2006-02-16 National Institute For Materials Science 酒石酸誘導体及び該誘導体により合成された高分子架橋体
WO2006085653A1 (ja) * 2005-02-14 2006-08-17 Medgel Corporation 医療用ハイドロゲル
WO2006136870A1 (fr) * 2005-06-21 2006-12-28 Antoine Turzi Hydrogel bioresorbable

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002020310A (ja) * 2000-06-30 2002-01-23 Nipro Corp 組織癒着防止剤
WO2006016600A1 (ja) * 2004-08-10 2006-02-16 National Institute For Materials Science 酒石酸誘導体及び該誘導体により合成された高分子架橋体
WO2006085653A1 (ja) * 2005-02-14 2006-08-17 Medgel Corporation 医療用ハイドロゲル
WO2006136870A1 (fr) * 2005-06-21 2006-12-28 Antoine Turzi Hydrogel bioresorbable

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"The Society of Polymer Science, Japan Preprints of Research Group on Biochemical Polymer Symposium, 23 July, 2007 (23.07.07)", vol. 36TH, article YASUMUNE YAMAZOE: "Kessei Albumin o Mochiita Saibo Setchaku Seigyo", pages: 1 - 2 *
MOTOYUKI SUZUKI ET AL.: "Setchaku Izonsei Dobutsu Saibo no Fuchaku ni Oyobosu Kessei Tanpaku no Eikyo", MONTHLY JOURNAL OF INSTITUTE OF INDUSTRIAL SCIENCE, vol. 41, no. 3, March 1989 (1989-03-01), pages 175 - 178 *
YASUMUNE YAMAZOE ET AL.: "Kessei Albumin Film no Sakusei to Sono Bussei ni Kansuru Kenkyu", POLYMER PREPRINTS, JAPAN, vol. 50, no. 5, 7 May 2001 (2001-05-07), pages 1012 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102362856A (zh) * 2011-11-02 2012-02-29 珠海亿胜生物制药有限公司 重组牛碱性成纤维细胞生长因子外用溶液

Similar Documents

Publication Publication Date Title
USD648137S1 (en) Absorbent paper
USD591029S1 (en) Pocket
PE20081175A1 (es) Derivados de ftalazinona
USD629114S1 (en) Set of bandages for a healing wound
HRP20130387T1 (hr) Pripravak koji sadrži kitosan-glukan za zacjeljivanje rana i sprjeäśavanje lijepljenja zavoja na ranu
MY154909A (en) Novel thiophene derivatives
WO2008128028A3 (en) Solifenacin compositions
USD547989S1 (en) Pocket storage system
MX2010006241A (es) Derivados de aminotriazol como agonistas de alx.
WO2010039626A3 (en) Methods to communicate a timestamp to a storage system
IL200684A0 (en) Heterocyclic cyclopamine analog compounds, compositions comprising the same and uses thereof
WO2010132882A3 (en) Sublingual dexmedetomidine compositions and methods of use thereof
MX339255B (es) Una para usarse en el rejuvenecimiento de la piel que comprende, eosina y , un oxidante y un factor cicatrizante.
WO2009046372A3 (en) Modular vascular graft for low profile percutaneous delivery
WO2009063222A3 (en) Solid compositions
WO2012034079A3 (en) Macrolide dosage forms
WO2009059701A3 (de) Retardtabletten mit hydromorphon
IL205057A0 (en) Pyrimidyl indoline compound, composition comprising the same and uses thereof
WO2007139804A3 (en) Compositions and methods for treating conditions of the nail unit
MX2010001574A (es) Ligandos del receptor cannabinoide.
EP1769258A4 (en) Dynamic line rating system with real-time tracking of conductor creep to establish the maximum allowable conductor loading as limited by clearance
WO2012066488A3 (en) Bridged spiro[2.4]heptane ester derivatives
IN2012DN00311A (ja)
WO2011077239A3 (en) Slow release pharmaceutical compositions of iloperidone
WO2009007532A3 (fr) Utilisation d'une hemoglobine pour la preparation de pansements, et pansements ainsi prepares

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08848105

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08848105

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载